![Osi Pharmaceuticals logo](https://files.capedge.com/DEF%2014A/0000950123-06-005515/y20034dpy2003410.gif)
Company profile
Ticker
OSIP
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Oncogene Science Inc
SEC CIK
Corporate docs
IRS number
133159796
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
19 Oct 10
SC TO-I/A
Issuer tender offer statement (amended)
5 Aug 10
SC TO-I/A
Issuer tender offer statement (amended)
13 Jul 10
UPLOAD
Letter from SEC
2 Jul 10
SC TO-I/A
Issuer tender offer statement (amended)
29 Jun 10
UPLOAD
Letter from SEC
24 Jun 10
15-12G
Securities registration termination
18 Jun 10
SC TO-I/A
Issuer tender offer statement (amended)
18 Jun 10
SC TO-I
Issuer tender offer statement
17 Jun 10
EFFECT
Notice of effectiveness
14 Jun 10
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|